ID

25736

Description

PGX consent / withdrawal - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Mots-clés

Versions (1)
  1. 16/09/2017 16/09/2017 -
Détendeur de droits

glaxoSmithKline

Téléchargé le

16 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

PGX consent / withdrawal - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

Anglais

PGX consent / withdrawal - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

1 Formulaires  
PGX Consent
Description

PGX Consent

Alias
UMLS CUI-1
C0031325
UMLS CUI-2
C0021430
Has informed consent been obtained for PGx research?
Description

pharmacogenetics consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
If no, please specify whether subject declined, subject not asked by investigator or other.
Description

Reason for withdrawal

Type de données

integer

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0031325
If yes, please specify date obtained.
Description

Date informed consent

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0009797
UMLS CUI [1,3]
C0031325
Record PGx sample collection date.
Description

Pharmacogenetics sample date

Type de données

date

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0011008
Pharmacogenetics withdraw consent
Description

Pharmacogenetics withdraw consent

Alias
UMLS CUI-1
C0031325
UMLS CUI-2
C2349954
UMLS CUI-3
C0021430
Has the subject withdrawn consent for PGx research?
Description

Pharmacogenetics withdraw consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0021430
Did the subject request sample destruction?
Description

PGx sample destruction

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C1948029
If yes, please specify whether subjects request, screen failure or other.
Description

Reson for PGx consent withdrawal

Type de données

integer

Alias
UMLS CUI [1,1]
C0566251
UMLS CUI [1,2]
C0031325
UMLS CUI [1,3]
C2349954
UMLS CUI [1,4]
C0021430
Retour au début de la page

Similar models

PGX consent / withdrawal - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
PGX Consent
C0031325 (UMLS CUI-1)
C0021430 (UMLS CUI-2)
pharmacogenetics consent
Item
Has informed consent been obtained for PGx research?
boolean
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Item
If no, please specify whether subject declined, subject not asked by investigator or other.
integer
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0031325 (UMLS CUI [1,3])
Reason for withdrawal
Code List
If no, please specify whether subject declined, subject not asked by investigator or other.
CL Item
Subject declined (1)
CL Item
Subject not asked by investigator (2)
CL Item
other (3)
Date informed consent
Item
If yes, please specify date obtained.
date
C0011008 (UMLS CUI [1,1])
C0009797 (UMLS CUI [1,2])
C0031325 (UMLS CUI [1,3])
Pharmacogenetics sample date
Item
Record PGx sample collection date.
date
C0031325 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
Pharmacogenetics withdraw consent
C0031325 (UMLS CUI-1)
C2349954 (UMLS CUI-2)
C0021430 (UMLS CUI-3)
Pharmacogenetics withdraw consent
Item
Has the subject withdrawn consent for PGx research?
boolean
C0031325 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
PGx sample destruction
Item
Did the subject request sample destruction?
boolean
C0031325 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
Item
If yes, please specify whether subjects request, screen failure or other.
integer
C0566251 (UMLS CUI [1,1])
C0031325 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
Reson for PGx consent withdrawal
Code List
If yes, please specify whether subjects request, screen failure or other.
CL Item
subjects request (1)
CL Item
screen failure (2)
CL Item
other (3)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial